Fortunato Morabito
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments 77
- Acute Myeloid Leukemia Research 30
- Hematopoietic Stem Cell Transplantation 27
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 121
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 85
- Oncology top 2%
- Cancer Treatment and Pharmacology 23
- Immunology top 2%
- Immunodeficiency and Autoimmune Disorders 34
-
- Protein Degradation and Inhibitors 35
- Co-authors
- Massimo GentileVincenzo CalleaAntonino NeriCaterina StelitanoManlio FerrariniMassimo MartinoPasquale IacopinoGiovanna Cutrona
- Journals
- Journal of Clinical Oncology (5 papers)SHILAP Revista de lepidopterología (2 papers)Blood (32 papers)
- Partner nations
- ItalyUnited StatesSpain
In The Last Decade
Fortunato Morabito
278 papers receiving 4.9k citations
Peers
Comparison fields: 5 of 117
- Hematology 2.0k
- Genetics 1.7k
- Pathology and Forensic Medicine 1.3k
- Oncology 1.5k
- Immunology 1.1k
Countries citing papers authored by Fortunato Morabito
This map shows the geographic impact of Fortunato Morabito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fortunato Morabito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fortunato Morabito more than expected).
Fields of papers citing papers by Fortunato Morabito
This network shows the impact of papers produced by Fortunato Morabito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fortunato Morabito. The network helps show where Fortunato Morabito may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fortunato Morabito, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 0 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 5 | |
| 11 | 2023 | 2 | |
| 12 | 2021 | 32 | |
| 13 | 2021 | 12 | |
| 14 | 2020 | 10 | |
| 15 | 2019 | 3 | |
| 16 | 2017 | 66 | |
| 17 | 2013 | 12 | |
| 18 | 2010 | 38 | |
| 19 | 2009 | 75 | |
| 20 | 2006 | 137 |
About Fortunato Morabito
Fortunato Morabito is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 294 papers that have together received 5.0k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (121 papers), Lymphoma Diagnosis and Treatment (85 papers), Multiple Myeloma Research and Treatments (77 papers), Protein Degradation and Inhibitors (35 papers), Immunodeficiency and Autoimmune Disorders (34 papers), Acute Myeloid Leukemia Research (30 papers), Hematopoietic Stem Cell Transplantation (27 papers) and Cancer Treatment and Pharmacology (23 papers). The work is most often cited by research in Hematology (2.0k citations), Genetics (1.7k citations) and Pathology and Forensic Medicine (1.3k citations). Fortunato Morabito has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Massimo Gentile, Vincenzo Callea, Antonino Neri, Caterina Stelitano, Manlio Ferrarini, Massimo Martino, Pasquale Iacopino, Giovanna Cutrona, Ernesto Vigna and Stefano Molica. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.